Open forum infectious diseases · 2025
The Increased Risk for Postinfluenza Pneumonia Among Cystic Fibrosis Carriers-A Population-Based Study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Miller Aaron C, Boonstra D Erik, Cavanaugh Joe E, Abou Alaiwa Mahmoud H, Comellas Alejandro P, Hornick Douglas B, Stoltz David A, Polgreen Philip M
Аннотация
BACKGROUND: Influenza is strongly associated with an increased risk for subsequent bacterial pneumonia. Moreover, cystic fibrosis (CF) carriers are at increased risk for some pulmonary infections. The purpose of this study was to determine whether CF carriers are at greater risk for postinfluenza pneumonia than noncarriers.
METHODS: Using MarketScan insurance claims data (2001-2023), we identified a study cohort of 38 047 CF carriers and a cohort of 380 470 matched controls. We conducted 2 analyses using these cohorts. First, we assessed individual-level risk for experiencing pneumonia following an influenza infection. Second, because many cases of influenza often do not result in medical visits, we conducted a cohort-level analysis comparing the weekly incidence of pneumonia between CF carriers and noncarriers while accounting for weekly Centers for Disease Control and Prevention-reported influenzalike illnesses across multiple influenza seasons.
RESULTS: At an individual level, we found that the odds of developing pneumonia following a diagnosis of influenza were approximately 34% greater among CF carriers compared with noncarriers. Second, we found that while the incidence of influenza is not elevated among CF carriers, the incidence rate of pneumonia was about 55% greater among CF carriers compared with our control population.
CONCLUSIONS: Because 2%-11% of the population acquires influenza each year, and because there are >10-15 million CF carriers in the United States alone, a substantial number of cases of secondary pneumonia may be attributable to the CF carrier state.
METHODS: Using MarketScan insurance claims data (2001-2023), we identified a study cohort of 38 047 CF carriers and a cohort of 380 470 matched controls. We conducted 2 analyses using these cohorts. First, we assessed individual-level risk for experiencing pneumonia following an influenza infection. Second, because many cases of influenza often do not result in medical visits, we conducted a cohort-level analysis comparing the weekly incidence of pneumonia between CF carriers and noncarriers while accounting for weekly Centers for Disease Control and Prevention-reported influenzalike illnesses across multiple influenza seasons.
RESULTS: At an individual level, we found that the odds of developing pneumonia following a diagnosis of influenza were approximately 34% greater among CF carriers compared with noncarriers. Second, we found that while the incidence of influenza is not elevated among CF carriers, the incidence rate of pneumonia was about 55% greater among CF carriers compared with our control population.
CONCLUSIONS: Because 2%-11% of the population acquires influenza each year, and because there are >10-15 million CF carriers in the United States alone, a substantial number of cases of secondary pneumonia may be attributable to the CF carrier state.